Lymphangiogenesis in the liver of biliary atresia.


Journal

BMC gastroenterology
ISSN: 1471-230X
Titre abrégé: BMC Gastroenterol
Pays: England
ID NLM: 100968547

Informations de publication

Date de publication:
15 Aug 2024
Historique:
received: 12 04 2024
accepted: 13 08 2024
medline: 15 8 2024
pubmed: 15 8 2024
entrez: 14 8 2024
Statut: epublish

Résumé

Lymphatic vessels (LVs) play a crucial role in immune reactions by serving as the principal conduits for immune cells. However, to date, no study has analyzed the morphological changes in the LVs of patients with biliary atresia (BA). In this study, we aimed to determine the morphological changes in the LVs irrigating the liver in patients with BA, elucidate their correlations with the morphology of the portal vein (PV) branches, and discuss their etiopathogenetic significance. Morphometric analyses of liver biopsy specimens from patients treated between 1986 and 2016 were performed. The parameters measured were as follows: the whole liver area of the specimen, fibrotic area, number of LVs, LVs without patent lumen (designated as Ly0) and PV branches, and diameters of the LVs with patent lumen and the PVs. The numbers of LVs, Ly0, and PV branches per unit area of the whole liver specimen were significantly higher in patients with BA than in control participants with liver disease and those with normal livers. However, no correlation was observed between the fibrotic area and the average diameter of LVs or PVs, and between the fibrotic area and the number of LVs or PV branches. Furthermore, no correlation was observed between the total number of LVs and the number of PV branches. The present study showed a significant increase in the number of total LVs and Ly0, characterized by a high Ly0 to total LVs ratio, suggesting that lymphangiogenesis occurs in the liver of patients with BA.

Sections du résumé

BACKGROUND BACKGROUND
Lymphatic vessels (LVs) play a crucial role in immune reactions by serving as the principal conduits for immune cells. However, to date, no study has analyzed the morphological changes in the LVs of patients with biliary atresia (BA). In this study, we aimed to determine the morphological changes in the LVs irrigating the liver in patients with BA, elucidate their correlations with the morphology of the portal vein (PV) branches, and discuss their etiopathogenetic significance.
METHODS METHODS
Morphometric analyses of liver biopsy specimens from patients treated between 1986 and 2016 were performed. The parameters measured were as follows: the whole liver area of the specimen, fibrotic area, number of LVs, LVs without patent lumen (designated as Ly0) and PV branches, and diameters of the LVs with patent lumen and the PVs.
RESULTS RESULTS
The numbers of LVs, Ly0, and PV branches per unit area of the whole liver specimen were significantly higher in patients with BA than in control participants with liver disease and those with normal livers. However, no correlation was observed between the fibrotic area and the average diameter of LVs or PVs, and between the fibrotic area and the number of LVs or PV branches. Furthermore, no correlation was observed between the total number of LVs and the number of PV branches.
CONCLUSIONS CONCLUSIONS
The present study showed a significant increase in the number of total LVs and Ly0, characterized by a high Ly0 to total LVs ratio, suggesting that lymphangiogenesis occurs in the liver of patients with BA.

Identifiants

pubmed: 39143576
doi: 10.1186/s12876-024-03370-0
pii: 10.1186/s12876-024-03370-0
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

266

Informations de copyright

© 2024. The Author(s).

Références

Nio M, Ohi R. Biliary atresia. Semin Pediatr Surg. 2000;9:177–86.
doi: 10.1053/spsu.2000.18846 pubmed: 11112835
Russo P, Magee JC, Anders RA, Bove KE, Chung C, Cummings OW, et al. Key histopathologic features of liver biopsies that distinguish biliary atresia from other causes of infantile cholestasis and their correlation with outcome: a multicenter study. Am J Surg Pathol. 2016;40:1601–15.
doi: 10.1097/PAS.0000000000000755 pubmed: 27776008 pmcid: 5123664
Nio M. Japanese biliary atresia registry. Pediatr Surg Int. 2017;33:1319–25.
doi: 10.1007/s00383-017-4160-x pubmed: 29039049
Petersen C, Davenport M. Aetiology of biliary atresia: what is actually known? Orphanet J Rare Dis. 2013;8:128.
doi: 10.1186/1750-1172-8-128 pubmed: 23987231 pmcid: 3766137
Feldman AG, Mack CL. Biliary atresia: clinical lessons learned. J Pediatr Gastroenterol Nutr. 2015;61:167–75.
doi: 10.1097/MPG.0000000000000755 pubmed: 25658057
Muraji T. Maternal microchimerism in biliary atresia: are maternal cells effector cells, targets, or just bystanders? Chimerism. 2014;5:1–5.
doi: 10.4161/chim.28576 pubmed: 24670921 pmcid: 3988115
Vollmar B, Wolf B, Siegmund S, Katsen AD, Menger MD. Lymph vessel expansion and function in the development of hepatic fibrosis and cirrhosis. Am J Pathol. 1997;151:169–75.
pubmed: 9212743 pmcid: 1857941
Tanaka M, Iwakiri Y. The hepatic lymphatic vascular system: structure, function, markers, and lymphangiogenesis. Cell Mol Gastroenterol Hepatol. 2016;2:733–49.
doi: 10.1016/j.jcmgh.2016.09.002 pubmed: 28105461 pmcid: 5240041
Masuya R, Muraji T, Ohtani H, Mukai M, Onishi S, Harumatsu T, et al. Morphometric demonstration of portal vein stenosis and hepatic arterial medial hypertrophy in patients with biliary atresia. Pediatr Surg Int. 2019;35:529–37.
doi: 10.1007/s00383-019-04459-4 pubmed: 30762106
Srinivasan RS, Dillard ME, Lagutin OV, Lin FJ, Tsai S, Tsai MJ, et al. Lineage tracing demonstrates the venous origin of the mammalian lymphatic vasculature. Genes Dev. 2007;21:2422–32.
doi: 10.1101/gad.1588407 pubmed: 17908929 pmcid: 1993873
Ohuchi N, Ohi R, Takahashi T, Kasai M. Postoperative changes of intrahepatic portal veins in biliary atresia–a 3-D reconstruction study. J Pediatr Surg. 1986;21:10–4.
doi: 10.1016/S0022-3468(86)80641-8 pubmed: 3944749
Kasai M, Okamoto A, Ohi R, Yabe K, Matsumura Y. Changes of portal vein pressure and intrahepatic blood vessels after surgery for biliary atresia. J Pediatr Surg. 1981;16(2):152–9.
doi: 10.1016/S0022-3468(81)80342-9 pubmed: 7241316
Harumatsu T, Muraji T, Masuya R, Ohtani H, Nagai T, Yano K, et al. Microvascular proliferation of the portal vein branches in the liver of biliary atresia patients at Kasai operation is associated with a better long-term clinical outcome. Pediatr Surg Int. 2019;35:1437–41.
doi: 10.1007/s00383-019-04579-x pubmed: 31542827
Muraji T, Masuya R, Harumatsu T, Kawano T, Muto M, Ieiri S. New insights in understanding biliary atresia from the perspectives on maternal microchimerism. Front Pediatr. 2022;10:1007987.
doi: 10.3389/fped.2022.1007987 pubmed: 36210938 pmcid: 9539747
Oikawa H, Masuda T, Sato S, Yashima A, Suzuki K, Sato S, et al. Changes in lymph vessels and portal veins in the portal tract of patients with idiopathic portal hypertension: a morphometric study. Hepatology. 1998;27:1607–10.
doi: 10.1002/hep.510270621 pubmed: 9620334
Mertlitz S, Shi Y, Kalupa M, Grotzinger C, Mengwasser J, Riesner K, et al. Lymphangiogenesis is a feature of acute GVHD, and VEGFR-3 inhibition protects against experimental GVHD. Blood. 2017;129:1865–75.
doi: 10.1182/blood-2016-08-734210 pubmed: 28096093
Ishii E, Shimizu A, Kuwahara N, Arai T, Kataoka M, Wakamatsu K, et al. Lymphangiogenesis associated with acute cellular rejection in rat liver transplantation. Transplant Proc. 2010;42:4282–5.
doi: 10.1016/j.transproceed.2010.09.081 pubmed: 21168683
Chung C, Iwakiri Y. The lymphatic vascular system in liver diseases: its role in ascites formation. Clin Mol Hepatol. 2013;19:99–104.
doi: 10.3350/cmh.2013.19.2.99 pubmed: 23837133 pmcid: 3701854
Tanaka M, Iwakiri Y. Lymphatics in the liver. Curr Opin Immunol. 2018;53:137–42.
doi: 10.1016/j.coi.2018.04.028 pubmed: 29772409 pmcid: 6986420
Suda K, Muraji T, Ohtani H, Aiyoshi T, Sasaki T, Toma M, et al. Histological significance of hepatitis-like findings in biliary atresia: an analysis of 34 Japanese cases. Pediatr Int. 2019;61:364–8.
doi: 10.1111/ped.13816 pubmed: 30811786
Duarte RF, Delgado J, Shaw BE, Wrench DJ, Ethell M, Patch D, et al. Histologic features of the liver biopsy predict the clinical outcome for patients with graft-versus-host disease of the liver. Biol Blood Marrow Transplant. 2005;11:805–13.
doi: 10.1016/j.bbmt.2005.06.008 pubmed: 16182181
Salomao M, Dorritie K, Mapara MY, Sepulveda A. Histopathology of graft-vs-host disease of gastrointestinal tract and liver: an update. Am J Clin Pathol. 2016;145:591–603.
doi: 10.1093/ajcp/aqw050 pubmed: 27247365
Shulman HM, Sharma P, Amos D, Fenster LF, McDonald GB. A coded histologic study of hepatic graft-versus-host disease after human bone marrow transplantation. Hepatology. 1988;8:463–70.
doi: 10.1002/hep.1840080305 pubmed: 3131226

Auteurs

Seitaro Kosaka (S)

Department of Pediatric Surgery, Ibaraki Children's Hospital, Ibaraki, Japan. s-kosaka@juntendo.ac.jp.
Department of Pediatric General and Urogenital Surgery, Juntendo University School of Medicine, 3-3-13 Hongo, Bunkyo-Ku, Tokyo, Japan. s-kosaka@juntendo.ac.jp.

Toshihiro Muraji (T)

Department of Pediatric Surgery, Research Field in Medicine and Health Sciences, Medical and Dental Sciences Area, Research and Education Assembly, Kagoshima University, Kagoshima, Japan.

Haruo Ohtani (H)

Department of Pathology, Ibaraki Children's Hospital, Ibaraki, Japan.

Toshio Harumatsu (T)

Department of Pediatric Surgery, Research Field in Medicine and Health Sciences, Medical and Dental Sciences Area, Research and Education Assembly, Kagoshima University, Kagoshima, Japan.

Sakika Shimizu (S)

Department of Pediatric Surgery, Ibaraki Children's Hospital, Ibaraki, Japan.

Miki Toma (M)

Department of Pediatric Surgery, Ibaraki Children's Hospital, Ibaraki, Japan.

Toshihiro Yanai (T)

Department of Pediatric Surgery, Ibaraki Children's Hospital, Ibaraki, Japan.

Satoshi Ieiri (S)

Department of Pediatric Surgery, Research Field in Medicine and Health Sciences, Medical and Dental Sciences Area, Research and Education Assembly, Kagoshima University, Kagoshima, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH